YOUNGCHULCHO CHO

Prof. YOUNGCHULCHO CHO

Asan Medical Center, University of Ulsan College of Medicine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2017 in Materials
Verified
Journal Article
Open access
PDF file
AGAmar Prasad Gupta
Amar Prasad Gupta
SPSangjun PARK
Sangjun PARK
SYSeung Jun Yeo
Seung Jun Yeo
JJJaeik Jung
Jaeik Jung
CCChonggil Cho
Chonggil Cho
Jehwang RyuJehwang Ryu
Jehwang Ryu
We report the design, fabrication and characterization of a carbon nanotube enabled open-type X-ray system for medical imaging. We directly grew the carbon nanotubes used as electron emitter for electron gun on a non-polished raw metallic rectangular-rounded substrate with an area of 0.1377 cm2 through a plasma enhanced chemical vapor deposition system. The stable field emission properties with triode electrodes after electrical aging treatment showed an anode emission current of 0.63 mA at a gate field of 7.51 V/μm. The 4.5-inch cubic shape open type X-ray system was developed consisting of an X-ray aperture, a vacuum part, an anode high voltage part, and a field emission electron gun including three electrodes with focusing, gate and cathode electrodes. Using this system, we obtained high-resolution X-ray images accelerated at 42–70 kV voltage by digital switching control between emitter and ground electrode.

Verified
Journal Article
Open access
PDF file
ALAmy Junghyun Lee
Amy Junghyun Lee
KKKyung Won Kim
Kyung Won Kim
YCYOUNGCHULCHO CHO
YOUNGCHULCHO CHO
YKYousun Ko
Yousun Ko
YSYu Sub Sung
Yu Sub Sung
MKMi-hyun Kim
Mi-hyun Kim
We evaluated the incidence of pseudoprogression and indeterminate response (IR) in patients with lymphoma treated with immune checkpoint inhibitors (ICIs). A systematic search of PubMed and EMBASE was performed up to 6 February 2021, using the keywords “lymphoma,” “immunotherapy,” and “pseudoprogression.” Random-effects models were used to calculate both pooled incidence of pseudoprogression patients with lymphoma and an IR according to LYRIC criteria, while the Higgins inconsistency index (I2) test and Cochran’s Q test were used for heterogeneity. Eight original articles were included, in which the number of patients ranged from 7 to 243. Among the lymphoma patients with ICIs, the pooled incidence of pseudoprogression was 10% (95% confidence interval [CI]: 0.06–0.17). There was no publication bias in Begg’s test (p = 0.14). Three articles were analyzed to determine the pooled incidence of pseudoprogression in patients with IR according to LYRIC criteria in a subgroup analysis, which was shown to be 19% (95% CI: 0.08–0.40). A significant proportion (10%) of patients with lymphoma treated with ICIs showed pseudoprogression, and 19% of patients with an IR response showed pseudoprogression and a delayed response. Immune-related response criteria such as LYRIC may be used for patients with lymphoma treated with ICIs.

9 March 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
SCSe Jin Choi
Se Jin Choi
KKKyung Won Kim
Kyung Won Kim
YKYousun Ko
Yousun Ko
YCYOUNGCHULCHO CHO
YOUNGCHULCHO CHO
JJJi-Sung Jang
Ji-Sung Jang
MKMiyoung Kim
Miyoung Kim
Background: To use the apparent diffusion coefficient (ADC) as reliable biomarkers, validation of MRI equipment performance and clinical acquisition protocols should be performed prior to application in patients. This study aims to validate various MRI equipment and clinical brain protocols for diffusion weighted imaging (DWI) using commercial phantom, and confirm the validated protocols in patients’ images. Methods: The performance of four different scanners and clinical brain protocols were validated using a Quantitative Imaging Biomarker Alliance (QIBA) diffusion phantom and cloud-based analysis tool. We evaluated the performance metrics regarding accuracy and repeatability of ADC measurement using QIBA profile. The validated clinical brain protocols were applied to 17 patients, and image quality and repeatability of ADC were assessed. Results: The MRI equipment performance of all four MRI scanners demonstrated high accuracy in ADC measurement (ADC bias, −2.3% to −0.4%), excellent linear correlation to the reference ADC value (slope, 0.9 to 1.0; R2, 0.999–1.000), and high short-term repeatability [within-subject-coefficient-of-variation (wCV), 0% to 0.3%]. The clinical protocols were also validated by fulfilling QIBA claims with high accuracy (ADC bias, −3.1% to −0.7%) and robust repeatability (wCV, 0% to 0.1%). Brain DWI acquired using the validated clinical protocols showed ideal image quality (mean score ≥ 2.9) and good repeatability (wCV, 1.8–2.2). Conclusions: The whole process of standardization of DWI demonstrated the robustness of ADC with high accuracy and repeatability across diverse MRI equipment and clinical protocols in accordance with the QIBA claims.

3 October 2013 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
YCYOUNGCHULCHO CHO
YOUNGCHULCHO CHO
Jin Hyoung KimJin Hyoung Kim
Jin Hyoung Kim
Jung-Hoon ParkJung-Hoon Park
Jung-Hoon Park
JSJi Hoon Shin
Ji Hoon Shin
HKHeung Kyu Ko
Heung Kyu Ko
HSHo-Young Song
Ho-Young Song